5Edwards JR. Meropenem: a microbiological overview[J].J Antimicrob Chemother, 1995,36(Suppl A) : 1-17. 被引量：1
6Sumita Y, Fukasawa M. Potent activity of meropenem against Esehericua eoli arising from its simultaneous binding m penicil lin-binding proteins 2 and 3[J].J Antimicrob Chemother, 1995, 36(1 ) :53-64. 被引量：1
7Aldrige KE, Morice N, Schiro DD. In vitro activity of biapenem (L- 627), a new carbapenem, against anaerobes [J ]. Antimicrob Agent s Chemother, 1994,38 : 889-893. 被引量：1
8Wiseman LR, Wagstaff AJ ,- Brogden RN,et al. Meropenerra A review of its antibacterial activity, pharmacokinetic properties and clinical efficacy[J]. Drugs, 1995,50(1 ) :73-101. 被引量：1
9Verwaest C. Meropenem versus impenem/eilastatin as empirical monotherapy for serious bacterial infections in the intensive care unit [J ]. Clin Microbiol Infect, 2000,6 (6) :294-302. 被引量：1
10Hurst M, Lamb HM. Meropenem: a review of its use in patients in intensive care[J].Drugs,2000,59(3);653-680. 被引量：1
